Transgene S.A.

Overview

Transgene S.A. is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases. The company is engaged in the development of a series of products based on viral vector technology that is intended to induce an immune system response against cancer. Its products are designed to activate the immune system to more effectively pursue and destroy targeted cancer cells.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Transgene S.A. in our records. PharmaTek screens the full directory against live FDA enforcement data.